Evaluation of Trends and Prognosis Over Time in Patients with AML Relapsing After Allogeneic Hematopoietic Cell Transplant Reveals Improved Survival for Young Patients in Recent Years.
Bazarbachi A, Schmid C, Labopin M, Beelen D, Wolfgang Blau I, Potter V, Niittyvuopio R, Socié G, Blaise D, Sanz J, Ciceri F, Abou Dalle I, Spyridonidis A, Bug G, Esteve J, Savani BN, Nagler A, Mohty M.
Bazarbachi A, et al. Among authors: abou dalle i.
Clin Cancer Res. 2020 Dec 15;26(24):6475-6482. doi: 10.1158/1078-0432.CCR-20-3134. Epub 2020 Sep 28.
Clin Cancer Res. 2020.
PMID: 32988970